CN1886367A - 稠环双阳离子抗原生动物药物及其前药 - Google Patents

稠环双阳离子抗原生动物药物及其前药 Download PDF

Info

Publication number
CN1886367A
CN1886367A CNA2004800347505A CN200480034750A CN1886367A CN 1886367 A CN1886367 A CN 1886367A CN A2004800347505 A CNA2004800347505 A CN A2004800347505A CN 200480034750 A CN200480034750 A CN 200480034750A CN 1886367 A CN1886367 A CN 1886367A
Authority
CN
China
Prior art keywords
alkyl
aryl
group
independently
following group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2004800347505A
Other languages
English (en)
Chinese (zh)
Inventor
戴维·W.·博伊金
理查德·R.·蒂德韦尔
戴维·W.·威尔逊
雷托·布伦
雷姆·K.·阿拉法
查德·E.·斯蒂芬斯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of North Carolina at Chapel Hill
Georgia State University Research Foundation Inc
Original Assignee
University of North Carolina at Chapel Hill
Georgia State University Research Foundation Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of North Carolina at Chapel Hill, Georgia State University Research Foundation Inc filed Critical University of North Carolina at Chapel Hill
Publication of CN1886367A publication Critical patent/CN1886367A/zh
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D219/00Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
    • C07D219/04Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C07D219/08Nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06Antimalarials
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C257/00Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
    • C07C257/10Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
    • C07C257/18Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to carbon atoms of six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/18Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to carbon atoms of six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/20Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
    • C07C279/24Y being a hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C291/00Compounds containing carbon and nitrogen and having functional groups not covered by groups C07C201/00 - C07C281/00
    • C07C291/02Compounds containing carbon and nitrogen and having functional groups not covered by groups C07C201/00 - C07C281/00 containing nitrogen-oxide bonds
    • C07C291/04Compounds containing carbon and nitrogen and having functional groups not covered by groups C07C201/00 - C07C281/00 containing nitrogen-oxide bonds containing amino-oxide bonds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00Systems containing at least three condensed rings
    • C07C2603/02Ortho- or ortho- and peri-condensed systems
    • C07C2603/04Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/06Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
    • C07C2603/10Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
    • C07C2603/12Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
    • C07C2603/18Fluorenes; Hydrogenated fluorenes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00Systems containing at least three condensed rings
    • C07C2603/02Ortho- or ortho- and peri-condensed systems
    • C07C2603/04Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/22Ortho- or ortho- and peri-condensed systems containing three rings containing only six-membered rings
    • C07C2603/24Anthracenes; Hydrogenated anthracenes
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
CNA2004800347505A 2003-11-24 2004-11-18 稠环双阳离子抗原生动物药物及其前药 Pending CN1886367A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US52501803P 2003-11-24 2003-11-24
US60/525,018 2003-11-24

Publications (1)

Publication Number Publication Date
CN1886367A true CN1886367A (zh) 2006-12-27

Family

ID=34632950

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2004800347505A Pending CN1886367A (zh) 2003-11-24 2004-11-18 稠环双阳离子抗原生动物药物及其前药

Country Status (7)

Country Link
US (1) US7825279B2 (enExample)
EP (1) EP1689705A4 (enExample)
JP (1) JP2007513888A (enExample)
CN (1) CN1886367A (enExample)
AU (1) AU2004292992A1 (enExample)
CA (1) CA2547972A1 (enExample)
WO (1) WO2005051296A2 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2687964A1 (en) 2007-06-01 2009-02-19 The Trustees Of Princeton University Treatment of viral infections by modulation of host cell metabolic pathways
FR2920775B1 (fr) * 2007-09-07 2009-11-06 Pharma Hydro Dev P H D Soc Par Nouveaux composes diaminophenothiazine, leur procede de preparation et leurs utilisations.
US8277026B2 (en) * 2008-01-16 2012-10-02 Zamtec Limited Printhead cartridge insertion protocol
CA2934523A1 (en) 2013-12-24 2015-07-02 University Of Florida Research Foundation, Inc. Phenazine derivatives as antimicrobial agents
WO2017011730A2 (en) * 2015-07-15 2017-01-19 University Of Florida Research Foundation, Incorporated Phenazine derivatives as antimicrobial agents
WO2018152436A1 (en) 2017-02-17 2018-08-23 University Of Research Foundation, Incorporated Phenazine derivatives as antimicrobial agents
US12060334B2 (en) 2021-03-12 2024-08-13 University Of Florida Research Foundation, Incorporated 3-substituted phenazine derivatives as antimicrobial agents
ES2950283B2 (es) 2022-03-04 2024-02-12 Consejo Superior Investigacion Compuestos derivados de 4-amino-n-(4-aminofenil)benzamida y analogos y uso de los mismos

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1374695A (en) * 1919-11-21 1921-04-12 Barrett Co Catalytic oxidation of fluorene
DE1014518B (de) * 1956-03-09 1957-08-29 Bayer Ag Verfahren zum Faerben und Bedrucken von Polymerisaten und Mischpolymerisaten des Acrylnitrils bzw. Dicyanaethylens
US4141992A (en) * 1975-08-22 1979-02-27 American Cyanamid Company Cycloalkylcarboxyamidines and halobenzamidines as anti-amebic agents
US5521190A (en) * 1993-05-27 1996-05-28 Fmc Corporation Insecticidal pterdines and 8-deazapteridines
US5521189A (en) * 1994-05-06 1996-05-28 The University Of Nc At Ch Methods of treating pneumocystis carinii pneumonia
US5677349A (en) * 1995-04-27 1997-10-14 Gilad; Gad M. Agmatine for the treatment of neurotrauma and neurodegenerative diseases
US5668167A (en) * 1995-06-07 1997-09-16 Duke University Methods of treating microbial infections
WO1996040138A1 (en) 1995-06-07 1996-12-19 The Administrators Of The Tulane Educational Fund Chloroquine analogs and methods of preventing and treating plasmodial disease
US5628984A (en) * 1995-07-31 1997-05-13 University Of North Carolina At Chapel Hill Method of detecting lung disease
WO2000010990A2 (en) * 1998-08-20 2000-03-02 University Of North Carolina At Chapel Hill Dicationic dibenzofuran and dibenzothiophene compounds and methods of use thereof
CA2361734A1 (en) * 1999-01-26 2000-10-12 Andre Rosowsky Pharmaceutically active compounds and methods of use thereof
FR2796642B1 (fr) * 1999-07-21 2001-10-19 Centre Nat Rech Scient Precurseurs de sels de bis-ammonium quaternaire et leurs applications comme prodrogues ayant une activite anti-parasitaire
JP2002097133A (ja) * 2000-07-17 2002-04-02 Shionogi & Co Ltd トリアゼン化合物を含有する抗マラリア剤および殺線虫剤
EP1545544A2 (en) * 2002-07-11 2005-06-29 Combinatorx, Incorporated Combinations of drugs for the treatment of neoplasms
US20050054708A1 (en) * 2003-07-28 2005-03-10 Nichols Matthew James Combinations of drugs for the treatment of neoplasms
ITMI20031754A1 (it) 2003-09-12 2005-03-13 Fabrizio Marcucci Composizione microbicida.

Also Published As

Publication number Publication date
WO2005051296A3 (en) 2005-07-28
EP1689705A2 (en) 2006-08-16
US20050165044A1 (en) 2005-07-28
WO2005051296A2 (en) 2005-06-09
JP2007513888A (ja) 2007-05-31
AU2004292992A1 (en) 2005-06-09
US7825279B2 (en) 2010-11-02
CA2547972A1 (en) 2005-06-09
EP1689705A4 (en) 2007-08-29

Similar Documents

Publication Publication Date Title
CN1128139C (zh) 新哌嗪衍生物及其制造方法
CN1151836C (zh) 用作传送活性剂的化合物和组合物
CN1152015C (zh) 新哌嗪衍生物及其制造方法
CN1930159A (zh) 作为抗原生动物药的新的双阳离子咪唑并[1,2-a]吡啶和5,6,7,8-四氢-咪唑并[1,2-a]吡啶化合物
CN1231464C (zh) 新型3-取代的脲衍生物及其药学应用
CN1097043C (zh) 新的杂环衍生物及其医药用途
CN1227466A (zh) 用作神经氨酸酶抑制剂的取代环戊烷化合物
CN1149214C (zh) 三唑并衍生物和含有它们作为有效组分的趋化因子抑制剂
CN1599738A (zh) 脲取代的咪唑并吡啶
CN1221339A (zh) 细胞Na+/H+ 交换泵(NHE)抑制剂在生产用于使血清脂质正常化的药物中的用途
CN1439006A (zh) 具有抗细菌、抗真菌或抗肿瘤活性的新的化合物
CN1684966A (zh) 新的腺嘌呤化合物及其用途
CN1491208A (zh) 酰化的6,7,8,9-四氢-5h-苯并环庚烯基胺和它们作为药物的用途
CN1260345A (zh) 酰肼化合物、其制备方法及其药物组合物
HK1042084A1 (en) Substituted benzimidazoles and their preparation and use
CN1106804A (zh) 1-苯碘酰-1,3-二氢-2h-苯并咪唑-2-酮衍生物
CN1252068A (zh) 3-哌啶基-4-氧基喹唑啉衍生物和含有该化合物的药物组合物
CN1281432A (zh) α-芳基-N-烷基硝酮类和含有该类物质的药物组合物
CN1166639C (zh) 抗疟的喹啉衍生物,其制备方法及用途
CN1886367A (zh) 稠环双阳离子抗原生动物药物及其前药
CN1095709A (zh) 15-脱氧斯普胍呤类似物,其制备方法及其治疗用途
CN1281585C (zh) 具有稠环基团的环二胺化合物
CN1503669A (zh) 抗病毒剂和病毒感染的治疗方法
CN1990477A (zh) 作为抗寄生虫药的线性双阳离子三联苯和它们的氮杂类似物
CN1807413A (zh) 咔唑磺酰胺衍生物及其制备方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication